This company has been acquired
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cerevel Therapeutics Holdings Gestion
Gestion contrôle des critères 2/4
Cerevel Therapeutics Holdings' CEO is Ron Renaud, appointed in Jun 2023, has a tenure of 1.17 years. total yearly compensation is $32.32M, comprised of 1.2% salary and 98.8% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth $10.98M. The average tenure of the management team and the board of directors is 3.7 years and 5.4 years respectively.
Informations clés
Ron Renaud
Directeur général
US$32.3m
Rémunération totale
| Pourcentage du salaire du PDG | 1.2% |
| Durée du mandat du directeur général | 1.2yrs |
| Propriété du PDG | 0.1% |
| Durée moyenne d'occupation des postes de direction | 3.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5.4yrs |
Mises à jour récentes de la gestion
Recent updates
Cerevel Therapeutics Holdings (NASDAQ:CERE) Has Debt But No Earnings; Should You Worry?
Apr 30
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Could Be 23% Above Their Intrinsic Value Estimate
Jan 02Cerevel overweight at Wells Fargo due to candidates with blockbuster potential
Sep 26Cerevel Therapeutics prices $300M in notes offering, $254M in stock offering
Aug 12Cerevel Therapeutics GAAP EPS of -$0.61 misses by $0.13
Aug 01Cerevel: The Next Big Thing In CNS Disease? Maybe If The Market Wasn't So Crowded
Jul 08Cerevel Therapeutics: Pfizer's Neurology Spin-Off
Jul 14We're Not Very Worried About Cerevel Therapeutics Holdings' (NASDAQ:CERE) Cash Burn Rate
Jun 09Is Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Popular Amongst Institutions?
Jan 29Cerevel Therapeutics (CERE) Investor Presentation - Slideshow
Nov 18Cerevel Therapeutics reports Q3 results
Nov 16Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$460m |
| Dec 31 2023 | US$32m | US$375k | -US$433m |
Rémunération vs marché: Ron's total compensation ($USD32.32M) is above average for companies of similar size in the US market ($USD8.50M).
Rémunération et revenus: Insufficient data to compare Ron's compensation with company performance.
PDG
Ron Renaud (55 yo)
1.2yrs
Titularisation
US$32,322,358
Compensation
Mr. Ronald C. Renaud, also known as Ron, Jr., M.B.A., serves as President, CEO & Director at Cerevel Therapeutics Holdings, Inc. since June 12, 2023. He served as Managing Director at Bain Capital Life Sci...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 5.8yrs | US$31.98m | 0.0086% $ 702.8k | |
| President | 1.2yrs | US$32.32m | 0.13% $ 11.0m | |
| Chief Financial Officer | 1.3yrs | US$4.63m | 0.0093% $ 760.2k | |
| Senior VP of Finance & Chief Accounting Officer | 4.9yrs | US$1.21m | 0.0097% $ 797.0k | |
| Chief Scientific Officer | 5.3yrs | US$3.45m | 0.0035% $ 286.7k | |
| Chief Medical Officer | 5.6yrs | US$4.13m | 0.0080% $ 659.4k | |
| Chief Business Development & Strategic Operations Officer | 1.2yrs | US$3.55m | 0.025% $ 2.1m | |
| Vice President of Investor Relations | no data | pas de données | pas de données | |
| Chief Legal Officer & Corporate Secretary | 3.3yrs | US$3.19m | 0.0040% $ 325.2k | |
| Chief Human Resources Officer | 5.3yrs | pas de données | 0.014% $ 1.1m | |
| Chief Corporate Affairs Officer & Head of Commercial Strategy | 4.1yrs | US$3.92m | 0.0059% $ 479.2k |
3.7yrs
Durée moyenne de l'emploi
54yo
Âge moyen
Gestion expérimentée: CERE's management team is considered experienced (3.7 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 5.8yrs | US$31.98m | 0.0086% $ 702.8k | |
| President | 1.2yrs | US$32.32m | 0.13% $ 11.0m | |
| Independent Director | 5.2yrs | US$513.93k | 0.027% $ 2.2m | |
| Independent Director | 5.9yrs | US$486.49k | 0.017% $ 1.4m | |
| Independent Director | 3.6yrs | US$485.48k | 0.0018% $ 147.4k | |
| Lead Independent Director | 5.7yrs | US$564.65k | 0.025% $ 2.1m | |
| Independent Director | 5.9yrs | US$501.43k | 0.0018% $ 147.4k | |
| Independent Director | 5.9yrs | US$504.65k | 0.0018% $ 147.4k | |
| Independent Director | 5.9yrs | US$505.21k | 0.0018% $ 147.4k | |
| Independent Director | 3.7yrs | US$485.48k | 0% $ 0 | |
| Independent Director | 2.2yrs | pas de données | pas de données | |
| Independent Director | 3.6yrs | pas de données | pas de données |
5.4yrs
Durée moyenne de l'emploi
62.5yo
Âge moyen
Conseil d'administration expérimenté: CERE's board of directors are considered experienced (5.4 years average tenure).